We all hear a lot about fillers. Celebs love them (even if they pretend they don’t!) and when applied expertly, the results are both natural-looking and stunning. When such beautiful outcomes are already possible and achievable, why change the formula? Ashley Pallett investigates new Vycross® range – and what these new fillers might mean for you.
Allergan’s VOLUMA®, VOLBELLA® and VOLIFT® are the latest generation of dermal fillers, and they share one very unique feature: Vycross technology.
Vycross is very clever stuff, made up of 90% low-molecular-weight hyaluronic acid and only 10% high-molecular-weight hyaluronic acid (HMWHA). In comparison, traditional fillers are 100% high molecular weight hyaluronic acid. Though you can get great results with 100% high HMWHA, it demands the very highest standards of aesthetic skill for a really natural looking result, and regardless of the practitioner’s skill, results won’t last as long.
There’s lots of science at play here, but you’re more interested in the results, right? So we’ll skip straight there…
Why Vycross is great news for you
The three main benefits of Vycross technology for you are: smoother application, long-lasting results, and a very natural look and feel. Let’s take a closer look at those benefits one by one…
The smoothness of the treatment means it flows easily during the injection and then integrates more fully into your skin – say goodbye to any scares about lumps and bumps.
Better still, Vycross products include an anaesthetic – Lidocaine – so are more comfortable in application.
Finally, they are clinically proven to cause less swelling and bruising. This means that if you’re worried about a painful injection or needing down time after your treatment, you can relax – Vycross technology is as pain-free as possible, and helps you get back to daily life more quickly after a treatment.
One of the biggest benefits of Vycross technology is just how long the results last – after all, talented practitioners like our clinical team have been delivering beautiful, natural-looking treatments with traditional fillers for years. However, when you ask for Vycross, you can expect new, redefined beauty that stay fresh and stunning for a year or more, depending on the area treated:
- VOLUMA® – to restore volume to chin, cheeks, and cheekbone, lasts up to 18 months.
- VOLBELLA® – designed specifically for natural-looking lip augmentation, lasts up to 12 months.
- VOLIFT® – for lips, smokers’ lines and naso-labial folds, last up to 15 months.
Rather than tell you, why not see for yourself:
VOLUMA images (Amanda, Deborah, Sarah and Violet) – treatments conducted by Dr Raina zarb Adami, images owned by Allergan Ltd.
VOLBELLA images – treatments conducted by Dr Rita Rakus, images owned by Allergan Ltd.
But are they safe – up to 18 months sounds a long time?
You know how we feel about safety here at DestinationSkin – safer is our standard, so you can feel confident when you opt for the Vycross range.
VOLUMA® , VOLBELLA® and VOLIFT® are all premium products, fully approved under the European medical devices legislation. This means they have passed EU standards for safety and efficacy and have been approved for use.
The next generation is here
All in all, it sounds like it’s true – fillers really have evolved. But we’ll leave the last words to some ladies who’ve tried the treatments already:
“It makes me feel really good when friends and family say I look really well, especially when they can’t pinpoint exactly why I look better.”
Kelly, Age 31
“It is fair to say I’m ecstatic with the results I’ve had from having the VOLBELLA® injections.”
Joy, Age 25
“I definitely feel it has been a natural change, so much so that people say that you look a bit glam, what’s changed?”
Georgie, Age 23
“Since the treatment I’ve had enough confidence to go out and buy a red lipstick for the first time!”
Clair, Age 35
So if you’re ready for beautiful long-lasting results, why not book an appointment – in you could be enjoying fuller lips, fewer lines and youthful fullness for a year or more!.
treat any clients under
the age of 18.